CBT-Plus: A meta-analysis of cognitive behavioral therapy augmentation strategies for obsessive-compulsive disorder

Andersson, 2015, D-cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: A randomized clinical trial, JAMA Psychiatry, 72, 659, 10.1001/jamapsychiatry.2015.0546 Bandura, 1977, Self-efficacy: Toward a unifying theory of behavioral change, Psychological Review, 84, 191, 10.1037/0033-295X.84.2.191 Barlow, 2017 Borenstein, 2009 Bussing, 2013, Psychometric properties of the treatment-emergent activation and suicidality assessment profile (TEASAP) in youth with OCD, Psychiatry Research, 205, 253, 10.1016/j.psychres.2012.09.019 Chasson, 2010, Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine, Behaviour Research and Therapy, 48, 675, 10.1016/j.brat.2010.03.007 Cohen, 1988, A power primer, Psychological Bulletin, 112, 155, 10.1037/0033-2909.112.1.155 Deng, 2014, Randomized controlled trial of adjunctive EEG-biofeedback treatment of obsessive-compulsive disorder, Shanghai Archives of Psychiatry, 26, 272 Duval, 2000, Trim and fill: A simple funnel‐plot–based method of testing and adjusting for publication bias in meta‐analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x Farrell, 2013, Difficult-to-treatt pediatric obsessive-compulsive disorder: Feasibility and preliminary results of a randomized pilot trial of d-cycloserince-augmented behavior therapy, Depression and Anxiety, 30, 723, 10.1002/da.22132 Fentz, 2014, The mediational role of panic self-efficacy in cognitive behavioral therapy for panic disorder: A systematic review and meta-analysis, Behaviour Research and Therapy, 60, 23, 10.1016/j.brat.2014.06.003 Foa, 2005, Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder, American Journal of Psychiatry, 162, 151, 10.1176/appi.ajp.162.1.151 Foa, 2012 Franklin, 2011, Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: The Pediatric OCD Treatment Study II (POTS II) randomized controlled trial, JAMA, 306, 1224, 10.1001/jama.2011.1344 Goodman, 1989, The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability, Archives of General Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 Grunes, 2001, Family involvement in the behavioral treatment of obsessive-compulsive disorder: A preliminary investigation, Behavior Therapy, 32, 803, 10.1016/S0005-7894(01)80022-8 Hofmann, 2014, D-cycloserine for treating anxiety disorders: Making good exposures better and bad exposures worse, Depression and Anxiety, 31, 175, 10.1002/da.22257 Hohagen, 1998, Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: Results of a multicentre study, The British Journal of Psychiatry, 173, 71, 10.1192/S0007125000297924 Key, 2017, Mindfulness‐based cognitive therapy as an augmentation treatment for obsessive–compulsive disorder, Clinical Psychology & psychotherapy, 24, 1109, 10.1002/cpp.2076 Kushner, 2007, D-cycloserine augmented exposure therapy for obsessive-compulsive disorder, Biological Psychiatry, 62, 835, 10.1016/j.biopsych.2006.12.020 Lebowitz, 2012, Family accommodation in obsessive–compulsive disorder, Expert Review of Neurotherapeutics, 12, 229, 10.1586/ern.11.200 Mataix-Cols, 2017, D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data, JAMA Psychiatry, 74, 501, 10.1001/jamapsychiatry.2016.3955 Mataix-Cols, 2014, Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: Pilot randomised controlled trial, The British Journal of Psychiatry, 204, 77, 10.1192/bjp.bp.113.126284 Merlo, 2010, Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive–compulsive disorder: A preliminary study, Cognitive Behaviour Therapy, 39, 24, 10.1080/16506070902831773 Meyer, 2010, A randomized clinical trial to examine enhancing cognitive-behavioral group therapy for obsessive-compulsive disorder with motivational interviewing and thought mapping, Behavioural and Cognitive Psychotherapy, 38, 319, 10.1017/S1352465810000111 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, PLoS Medicine, 6, 10.1371/journal.pmed.1000097 Morris, 2008, Estimating effect sizes from pretest-posttest-control group designs, Organizational Research Methods, 11, 364, 10.1177/1094428106291059 Norberg, 2008, A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy, Biological Psychiatry, 63, 1118, 10.1016/j.biopsych.2008.01.012 Olatunji, 2013, Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators, Journal of Psychiatric Research, 47, 33, 10.1016/j.jpsychires.2012.08.020 Öst, 2008, Efficacy of the third wave of behavioral therapies: A systematic review and meta-analysis, Behaviour Research and Therapy, 46, 296, 10.1016/j.brat.2007.12.005 Öst, 2015, Cognitive behavioral treatments of obsessive–compulsive disorder. A systematic review and meta-analysis of studies published 1993–2014, Clinical Psychology Review, 40, 156, 10.1016/j.cpr.2015.06.003 Öst, 2016, Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis, Journal of Anxiety Disorders, 43, 58, 10.1016/j.janxdis.2016.08.003 Pediatric OCD Treatment Study (POTS) Team, 2004, Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial, JAMA, 292, 1969, 10.1001/jama.292.16.1969 Peris, 2008, Parental attitudes, beliefs, and responses to childhood obsessive compulsive disorder: The parental attitudes and behaviors scale, Child & Family Behavior Therapy, 30, 199, 10.1080/07317100802275447 Peris, 2017, Targeted family intervention for complex cases of pediatric obsessive-compulsive disorder: A randomized controlled trial, Journal of the American Academy of Child & Adolescent Psychiatry, 56, 1034, 10.1016/j.jaac.2017.10.008 Piacentini, 2007 Pigott, 1999, A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder, The Journal of Clinical Psychiatry, 10.4088/JCP.v60n0206 R Core Team, 2016 Randall, 2016, Motivational interviewing as an adjunct to cognitive behavior therapy for anxiety disorders: A critical review of the literature, Cognitive and Behavioral Practice Reynolds, 2013, Randomized controlled trial of parent-enhanced CBT compared with individual CBT for obsessive-compulsive disorder in young people, Journal of Consulting and Clinical Psychology, 81, 1021, 10.1037/a0034429 Rollnick, 1995, What is motivational interviewing?, Behavioural and Cognitive Psychotherapy, 23, 325, 10.1017/S135246580001643X Rosa-Alcázar, 2015, Psychological treatment of obsessive-compulsive disorder in children and adolescents: A meta-analysis, The Spanish Journal of Psychology, 18, E20, 10.1017/sjp.2015.22 Rosen, 1999, Effects of SSRIs on sexual function: A critical review, Journal of Clinical Psychopharmacology, 19, 67, 10.1097/00004714-199902000-00013 Salemink, 2015, Augmentation of treatment as usual with online cognitive bias modification of interpretation training in adolescents with obsessive compulsive disorder: A pilot study, Journal of Behavior Therapy and Experimental Psychiatry, 49, 112, 10.1016/j.jbtep.2015.02.003 Scahill, 1997, Children's Yale-Brown obsessive compulsive scale: Reliability and validity, Journal of the American Academy of Child & Adolescent Psychiatry, 36, 844, 10.1097/00004583-199706000-00023 Simpson, 2013, Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: A randomized clinical trial, JAMA Psychiatry, 70, 1190, 10.1001/jamapsychiatry.2013.1932 Simpson, 2008, A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder, American Journal of Psychiatry, 165, 621, 10.1176/appi.ajp.2007.07091440 Simpson, 2010, Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder, Behaviour Research and Therapy, 48, 941, 10.1016/j.brat.2010.05.026 Soomro, 2008, Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD), The Cochrane Library Storch, 2013, Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive–compulsive disorder, Behaviour Research and Therapy, 51, 823, 10.1016/j.brat.2013.09.007 Storch, 2017 Storch, 2010, Development and psychometric evaluation of the Yale–Brown obsessive-compulsive scale—second edition, Psychological Assessment, 22, 223, 10.1037/a0018492 Storch, 2016, Efficacy of augmentation of cognitive behavior therapy with weight-adjusted D-cycloserine vs placebo in pediatric obsessive-compulsive disorder: A randomized clinical trial, JAMA Psychiatry, 73, 779, 10.1001/jamapsychiatry.2016.1128 Strauss, 2018, Mindfulness-based exposure and response prevention for obsessive compulsive disorder: Findings from a pilot randomised controlled trial, Journal of Anxiety Disorders, 10.1016/j.janxdis.2018.04.007 Thompson-Hollands, 2015, A randomized clinical trial of a brief family intervention to reduce accommodation in obsessive-compulsive disorder: A preliminary study, Behavior Therapy, 46, 218, 10.1016/j.beth.2014.11.001 Thompson-Hollands, J., Edson, A., Tompson, M. C., & Comer, J. S. (2014). Family involvement in the psychological treatment of obsessive–compulsive disorder: A meta-analysis. Tolin, 2017, Can cognitive behavioral therapy for anxiety and depression be improved with pharmacotherapy? A Meta-analysis, Psychiatric Clinics, 40, 715 Tolin, 2007, A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials, Behavior Therapy, 38, 179, 10.1016/j.beth.2006.07.001 Treanor, 2017, Integrating technology and evidence-based treatments: Insights from leaders in the field on the 50th anniversary of ABCT, The Behavior Therapist, 40, 24 Twohig, 2018, Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial, Behaviour Research and Therapy, 10.1016/j.brat.2018.06.005 Van Balkom, 1998, Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder, The Journal of Nervous and Mental Disease, 186, 492, 10.1097/00005053-199808000-00007 Wilhelm, 2008, Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder, American Journal of Psychiatry, 165, 335, 10.1176/appi.ajp.2007.07050776 Wu, 2016, A meta-analysis of family accommodation and OCD symptom severity, Clinical Psychology Review, 45, 34, 10.1016/j.cpr.2016.03.003